Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating
CCORF Maintains Bioventus(BVS.US) With Buy Rating, Maintains Target Price $12
Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating, Raises Target Price to $17
Analysts Are Bullish on These Healthcare Stocks: Bioventus (BVS), Sight Sciences (SGHT)
Bioventus Analyst Ratings
CCORF Maintains Bioventus(BVS.US) With Buy Rating, Raises Target Price to $12
Bioventus Analyst Ratings
Buy Rating Affirmed: Bioventus's Strong Q2 Performance and Strategic Growth Outlook
Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating
Bioventus Analyst Ratings
Canaccord Genuity Maintains Buy on Bioventus, Raises Price Target to $8
Analysts Offer Insights on Healthcare Companies: QuidelOrtho (QDEL), Ligand Pharma (LGND) and Bioventus (BVS)
Bioventus Analyst Ratings
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), Bioventus (BVS) and Pliant Therapeutics (PLRX)
Analysts Offer Insights on Healthcare Companies: Clene (CLNN), REPRO-MED Systems (KRMD) and Bioventus (BVS)
Analysts Are Bullish on Top Healthcare Stocks: Bioventus (BVS), Palatin Technologies (PTN)
Canaccord Genuity Upgrades Bioventus to Buy, Raises Price Target to $7
Bioventus Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Augmedix (AUGX), Biodesix (BDSX) and Bioventus (BVS)
Analysts Offer Insights on Healthcare Companies: Aadi Bioscience (AADI) and Bioventus (BVS)